当前位置:首页 - 行情中心 - 福元医药(601089) - 财务分析 - 现金流量表

福元医药

(601089)

  

流通市值:98.83亿  总市值:98.83亿
流通股本:4.80亿   总股本:4.80亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金812,403,333.43,222,896,646.082,416,292,559.891,579,528,111.81
  收到的税费返还-721,226.14721,226.14721,226.14
  收到其他与经营活动有关的现金10,948,223.676,300,614.740,871,022.621,978,322.13
  经营活动现金流入小计823,351,5573,299,918,486.922,457,884,808.631,602,227,660.08
  购买商品、接受劳务支付的现金121,911,016.64612,332,336.02433,716,613.43282,064,387.68
  支付给职工以及为职工支付的现金245,534,514.04668,222,840.48512,862,659.8358,050,620.89
  支付的各项税费87,388,507.6350,726,265.68264,713,801.07196,214,203.99
  支付其他与经营活动有关的现金262,708,946.631,307,782,508.56932,420,005.06547,867,439.84
  经营活动现金流出小计717,542,984.912,939,063,950.742,143,713,079.361,384,196,652.4
  经营活动产生的现金流量净额105,808,572.09360,854,536.18314,171,729.27218,031,007.68
二、投资活动产生的现金流量:
  取得投资收益收到的现金5,500,178.0618,822,305.9716,642,246.7813,873,096.77
  处置固定资产、无形资产和其他长期资产收回的现金净额14,335885,027.71555,186.55114,086.55
  收到的其他与投资活动有关的现金1,995,800,0008,488,800,0007,290,000,0005,302,000,000
  投资活动现金流入小计2,001,314,513.068,508,507,333.687,307,197,433.335,315,987,183.32
  购建固定资产、无形资产和其他长期资产支付的现金28,694,361.99397,406,893.64346,089,558.6297,752,386.58
  支付其他与投资活动有关的现金2,110,000,0008,258,600,0006,109,800,0004,154,000,000
  投资活动现金流出小计2,138,694,361.998,656,006,893.646,455,889,558.64,451,752,386.58
  投资活动产生的现金流量净额-137,379,848.93-147,499,559.96851,307,874.73864,234,796.74
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金-68,000--
  筹资活动现金流入平衡项目-0--
  筹资活动现金流入小计-68,000--
  偿还债务支付的现金-40,000,00040,000,00040,000,000
  分配股利、利润或偿付利息支付的现金-234,241,491.67234,241,491.67234,241,491.67
  支付其他与筹资活动有关的现金6,857,274.9618,893,193.916,181,811.7610,449,698.61
  筹资活动现金流出小计6,857,274.96293,134,685.57290,423,303.43284,691,190.28
  筹资活动产生的现金流量净额-6,857,274.96-293,066,685.57-290,423,303.43-284,691,190.28
五、现金及现金等价物净增加额-38,428,551.8-79,711,709.35875,056,300.57797,574,614.14
  加:期初现金及现金等价物余额634,048,094.3713,759,803.65713,759,803.65713,759,803.65
  期末现金及现金等价物余额595,619,542.5634,048,094.31,588,816,104.221,511,334,417.79
补充资料:
  净利润-471,263,535-268,472,085.54
  资产减值准备-16,491,237.75-4,085,112.27
  固定资产和投资性房地产折旧-99,789,270.17-43,538,863.54
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-99,789,270.17-43,538,863.54
  无形资产摊销-13,037,758.87-6,580,177.16
  长期待摊费用摊销-8,578,688.83-4,066,452.43
  处置固定资产、无形资产和其他长期资产的损失--21,837.92-35,004.55
  固定资产报废损失-35,909.48-559,445.43
  财务费用-1,579,732.14-939,165.49
  投资损失--17,756,892.4--13,087,827.13
  递延所得税-5,375,090.64--12,798,187.08
  其中:递延所得税资产减少--1,083,400.81-284,470.69
    递延所得税负债增加-6,458,491.45--13,082,657.77
  存货的减少--81,600,255.67--16,767,055.63
  经营性应收项目的减少--127,886,859.16--4,535,638.12
  经营性应付项目的增加--46,564,461.39--72,068,066
  其他--582,576.88--494,469.82
  现金的期末余额-634,048,094.3-1,511,334,417.79
  减:现金的期初余额-713,759,803.65-713,759,803.65
  现金及现金等价物的净增加额--79,711,709.35-797,574,614.14
公告日期2026-04-252026-04-142025-10-302025-08-19
审计意见(境内)标准无保留意见
TOP↑